Skip to content

Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy

The Laryngeal Mask Airway Supreme (TM) is an Effective Alternative to Laryngoscope-guided Tracheal Intubation for Patients Undergoing Elective Laparoscopic Cholecystectomy-- A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02037958
Enrollment
76
Registered
2014-01-16
Start date
2011-04-30
Completion date
2012-01-31
Last updated
2014-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Choledocholithiasis

Brief summary

We hypothesise that the use of the LMA-Supreme provides greater ease of insertion and reduced haemodynamic variability during insertion compared to the tracheal tube, whilst still maintaining a patent airway to facilitate elective laparoscopic cholecystectomy in selected patients.

Detailed description

The Laryngeal Mask Airway Supreme(LMA-S) has been used successfully to maintain a patent airway for laparoscopic surgery. Our study compares the use of LMA-S with that of the tracheal tube (ETT) with respect to the ease of insertion and potential haemodynamic disturbance during insertion.

Interventions

Patients who receive the LMA-S

DEVICEEndotracheal Tube

Patients who receive endotracheal intubation

Sponsors

Changi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) Physical Status 1 and 2 * Undergoing elective laparoscopic cholecystectomy

Exclusion criteria

* BMI \> 30 * Known gastro-oesophageal reflux disease * predicted or documented difficult airway * contraindications to drugs in the standardized anaesthesia protocol

Design outcomes

Primary

MeasureTime frameDescription
Time to Effective AirwayBaselineTime to achieve effective airway was defined as time between removing the face-mask, inserting the airway device and obtaining a sustained square-wave capnograph trace with manual ventilation

Secondary

MeasureTime frameDescription
Number of attempts taken for successful placement of airway deviceBaselineNumber of attempts needed for successful placement of either the LMA-Supreme or the tracheal tube, as assigned
Number of attempts taken for successful placement of gastric tubeBaselineNumber of attempts needed for successful placement of gastric tube. Correct gastric tube placement was determined by positive suctioning of gastric contents or detection of injected air with epigastric auscultation.
Haemodynamic response to insertion of airway deviceBaseline, 1 min, 5 minSystolic blood pressure and heart rate at 0 min, 1 min, 5 min, starting from the time the face mask was removed from the patient's face.
Peak airway pressure during pneumoperitoneumAssessed intra-operatively, during the period of pneumoperitoneumPeak airway pressure recorded during pneumoperitoneum, measured during the surgery
Incidence of post-operative sore throatAssessed 1 hr after the surgery, at the Recovery AreaPatients were asked about the presence of sore throat - defined as the presence of constant pain in the throat, independent of swallowing, 1 hr after the end of surgery. No further follow-up.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026